Clinical Trial Update: A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Sonrotoclax plus Zanubrutinib versus Venetoclax plus Acalabrutinib in adults with previously untreated chronic lymphocytic leukemia; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• Sonrotoclax
• Venetoclax (venetoclax)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: RECRUITING